LPT · LPT – Laser based Proton Therapy sysLPT – Laser based Proton Therapy system, Harnessing High Intensity Lasers Physics for Cancer Treatment Proton Therapy

Cancer is a global problem with 14.1 million new cases occurring annually and an expected increase of 68% by 2030.Ensuring effective and safe treatment remains a significant challenge for healthcare organisations. Studies have shownproton therapy to be effective in treating many types of tumours, including tumours of the prostate, brain, head and neck,central nervous system, lung, and gastrointestinal system as well as cancers that cannot be removed completely by surgery.Proton therapy is the most advanced type of external-beam radiation therapy that uses protons at high energy to destroycancer cells. Proton therapy is routinely used for cancer treatment however it is limited by the sheer size and expense of thesystems. There are currently only 66 operational proton therapy facilities in the world, addressing only 3-5% of clinicaldemand.LPT is developing a proton therapy system that overcomes the presented challenges, saving up to 50% space and reducingcosts by up to 75%. LPT applies a patented approach to particle acceleration and beam delivery, combining nanotechnologywith Nobel- Prizewinning ultra-high-intensity lasers and advanced magnetics. These technological breakthroughsenable meaningful reductionin the size, complexity and cost of proton therapy systems that will enable the widespread adoption of proton therapy bothacross Europe and globally.The technology is supported by the Horizon 2020, SME instrument. The LPT project aims to take the innovation to the nextlevel through the collaboration of strong industrial and academia players. Together, HIL applied medical, THALESOptronique and INFN, will achieve fundamental milestones in the development of the commercial system, namely PT-100.This system will be constructed based on the Alpha system (developed with the support of SME instrument), with a higherrepetition rate and proton flux to enable clinical use and wide market adoption.